A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1926

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients ; day:24 ; month:4 ; year:2019 ; pages:1-11
Clinical pharmacokinetics ; (24.4.2019), 1-11

Creator: Smit, Cornelis
Wasmann, Roeland E.
Goulooze, Sebastiaan C.
Hazebroek, Eric J.
Dongen, Eric P. A. Van
Burgers, Desiree M. T.
Mouton, Johan W.
Brüggemann, Roger J. M.
Knibbe, Catherijne A. J.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40262-019-00762-4

URN: urn:nbn:de:101:1-2019051719100683505125

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Smit, Cornelis
Wasmann, Roeland E.
Goulooze, Sebastiaan C.
Hazebroek, Eric J.
Dongen, Eric P. A. Van
Burgers, Desiree M. T.
Mouton, Johan W.
Brüggemann, Roger J. M.
Knibbe, Catherijne A. J.
SpringerLink (Online service)

Other Objects (12)

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

Development of a dosing system for individualized therapy with oral films

PK-DB: pharmacokinetics database for individualized and stratified computational modeling

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

Development of a dosing system for individualized therapy with oral films

PK-DB: pharmacokinetics database for individualized and stratified computational modeling

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

Development of a dosing system for individualized therapy with oral films

PK-DB: pharmacokinetics database for individualized and stratified computational modeling

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

Development of a dosing system for individualized therapy with oral films

PK-DB: pharmacokinetics database for individualized and stratified computational modeling

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

Development of a dosing system for individualized therapy with oral films

PK-DB: pharmacokinetics database for individualized and stratified computational modeling

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

Development of a dosing system for individualized therapy with oral films

PK-DB: pharmacokinetics database for individualized and stratified computational modeling

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Related objects

Reset password